Boundless Bio, Inc.
BOLD$18M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaLA JOLLA
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 4, 2026
4wMarket Overview
Stock performance and key metrics
BOLD News
Catalyst Timeline
1 upcoming, 0 past
How BOLD's past catalysts played out
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is Boundless Bio, Inc.'s next FDA catalyst?→
Boundless Bio, Inc.'s (BOLD) next tracked catalyst is a Earnings expected August 4, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track BOLD biotech catalysts?→
Add BOLD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Boundless Bio, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply